tiprankstipranks
Trending News
More News >
Silexion Therapeutics Corp (SLXN)
:SLXN
US Market

Silexion Therapeutics (SLXN) Income Statement

Compare
212 Followers

Silexion Therapeutics Income Statement

Last quarter (Q3 2025), Silexion Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Silexion Therapeutics's net income was $-3.26M. See Silexion Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 12.57M$ 4.68M$ 3.86M$ 943.93K$ 195.86K
Depreciation and Amortization
$ 25.00K$ 45.00K$ 57.00K$ 0.00$ 0.00
EBITDA
$ -16.48M$ -4.64M$ -3.80M$ -755.00K$ -195.86K
Operating Income
$ -12.57M$ -4.68M$ -3.86M$ -943.93K$ -195.86K
Other Income/Expenses
$ -3.94M$ -395.00K$ 396.00K$ 188.72K$ 0.00
Pretax Income
$ -16.51M$ -5.08M$ -3.46M$ -755.22K$ -195.86K
Net Income
$ -16.44M$ -4.94M$ -3.21M$ -755.22K$ -195.86K
Per Share Metrics
Basic EPS
$ -2.64$ -4.42$ 0.03$ -0.05$ -0.01
Diluted EPS
$ -2.64$ -4.42$ 0.03$ -0.05$ -0.01
Weighted Average Shares Outstanding
6.24M 1.12M 16.73M 16.51M 16.51M
Weighted Average Shares Outstanding (Diluted)
6.24M 1.12M 16.73M 16.51M 16.51M
Currency in USD

Silexion Therapeutics Earnings and Revenue History